Stockscreener 앱 받기
0.6374
1.90%
0.0119
시간 외 거래:
1.96
1.3226
+207.50%
전일 마감가:
$0.6255
열려 있는:
$0.6067
하루 거래량:
466.55K
Relative Volume:
1.69
시가총액:
$29.67M
수익:
$2.82M
순이익/손실:
$-13.47M
주가수익비율:
-0.9374
EPS:
-0.68
순현금흐름:
$-13.61M
1주 성능:
+1.79%
1개월 성능:
+34.19%
6개월 성능:
-28.38%
1년 성능:
-45.52%
1일 변동 폭
$0.601
$0.7349
1주일 범위
$0.601
$0.7349
52주 변동 폭
$0.3954
$1.39
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
명칭
Neuroone Medical Technologies Corp
전화
(952) 426-1383
주소
7599 ANAGRAM DR, EDEN PRAIRIE
NMTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
20.26 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1555 | 349.69M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
MOBBW
Mobilicom Limited Warrants
|
0.2267 | 318.40M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
11.00 | 205.55M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.11 | 157.18M | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-03-29 | 다운그레이드 | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp 주식(NMTC)의 최신 뉴스
NeuroOne Medical Opens Exclusive Investor Access: CFO Hosts One-on-One Meetings at Plaza Hotel - Stock Titan
NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference - The Kingston Whig Standard
NeuroOne Medical Tech (NMTC) Coverage Initiated by Ladenburg Thalmann | NMTC Stock News - GuruFocus
This Okta Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
NeuroOne Earnings: Medical Tech Leader to Reveal Q2 2025 Growth Strategy and Financial Results - Stock Titan
NeuroOne Medical Technologies Corp [NMTC] Records 50-Day SMA of $0.8911 - knoxdaily.com
NeuroOne Medical Technologies Corp’s results are impressive - uspostnews.com
The Future of NeuroOne Medical Technologies Corp: Analyzing NMTC - investchronicle.com
NeuroOne Medical (NMTC) Files Early FDA Submission for Trigemina - GuruFocus
NeuroOne Medical (NMTC) Files Early FDA Submission for Trigeminal Nerve Ablation | NMTC Stock News - GuruFocus
NeuroOne files early FDA 510(k) for nerve ablation system - Investing.com
NeuroOne's Revolutionary Facial Pain Treatment Advances: FDA Review Next for 95% Effective Device - Stock Titan
EXCLUSIVE: NeuroOne Submits FDA Marketing Application For OneRF Trigeminal Nerve Ablation System For Facial Pain - Benzinga
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Regulatory Success ... - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call - GuruFocus
CTEK Expects Significant Revenue Growth by Fiscal Year 2025 | NMTC Stock News - GuruFocus
NeuroOne Medical (NMTC) Expands Partnership with Zimmer Biomet and Secures Funding | NMTC Stock News - GuruFocus
Neuroone Medical Technologies Corp -Company Now Fully Funded Through At Least Fiscal 2026 - marketscreener.com
NeuroOne secures funding through fiscal 2026, unaffected by tariffs - Investing.com
NeuroOne Secures $11.3M in Fresh Capital, Forecasts Triple-Digit Growth - Stock Titan
NeuroOne Medical (NMTC) Gains Attention with Successful Pediatric Epilepsy Treatment | NMTC Stock News - GuruFocus
Breakthrough: Teen Goes from 10 Seizures Per Night to Zero with New Brain Treatment - Stock Titan
Teen goes from 10 nightly seizures to zero with brain implant - Fox News
Ronald McClurg Spends US$100k On NeuroOne Medical Technologies Stock - Yahoo
NeuroOne Medical Technologies CEO buys $50,000 in common stock By Investing.com - Investing.com India
NeuroOne Medical Technologies CEO buys $50,000 in common stock - Investing.com Australia
NeuroOne Medical’s CFO Ronald McClurg buys $100,000 in stock By Investing.com - Investing.com South Africa
NeuroOne Medical's CFO Ronald McClurg buys $100,000 in stock - Investing.com
NeuroOne Executives Make Significant Stock Purchases - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet - Benzinga
NeuroOne Announces Proposed Public Offering Of Common Stock To Raise Capital For Growth - Nasdaq
Neuroone stock hits 52-week low at $0.48 amid market challenges By Investing.com - Investing.com South Africa
Neuroone stock hits 52-week low at $0.48 amid market challenges - Investing.com
NeuroOne (NMTC) Announces $8 Million Public Offering - GuruFocus
Dow Tumbles 1,100 Points; US Economy Adds 228,000 Jobs In March - Benzinga
NeuroOne Medical Technologies prices $8 million public offering of common stock - MSN
NeuroOne sets price for 16 million share offering - Investing.com
NeuroOne Raises $8M: Inside the Major Public Offering That's Catching Investor Attention - Stock Titan
Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
NeuroOne announces public offering of common stock - Investing.com
NeuroOne Medical Announces Strategic Stock Offering with Ladenburg Thalmann - Stock Titan
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Fostering clinician-led biotech innovation - Medical Economics
Game-Changing Epilepsy Innovation: NeuroOne's FDA-Cleared Device Transforms Brain Treatment - StockTitan
NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy - Quantisnow
Breakthrough: First-Ever FDA-Cleared Device Transforms Epilepsy Treatment for 50M Patients - StockTitan
Tariffs and medical devices: What has the industry response been? - Medical Economics
NeuroOne Targets May 2025 FDA Submission For OneRF Trigeminal Nerve Ablation System - Nasdaq
NeuroOne accelerates FDA submission timeline for nerve ablation tech - Mass Device
Neuroone Medical Technologies Corp (NMTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
11.62%
0.20%
자본화:
|
볼륨(24시간):